HU9303025D0 - 4-aryl-3(jheteroaryl-ureido)-quinoline derivatives and pharmaceutical preparatives containing them - Google Patents

4-aryl-3(jheteroaryl-ureido)-quinoline derivatives and pharmaceutical preparatives containing them

Info

Publication number
HU9303025D0
HU9303025D0 HU9303025A HU9303025A HU9303025D0 HU 9303025 D0 HU9303025 D0 HU 9303025D0 HU 9303025 A HU9303025 A HU 9303025A HU 9303025 A HU9303025 A HU 9303025A HU 9303025 D0 HU9303025 D0 HU 9303025D0
Authority
HU
Hungary
Prior art keywords
jheteroaryl
ureido
aryl
quinoline derivatives
preparatives containing
Prior art date
Application number
HU9303025A
Other languages
Hungarian (hu)
Other versions
HUT65748A (en
Inventor
Ernest S Hamanaka
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU9303025D0 publication Critical patent/HU9303025D0/en
Publication of HUT65748A publication Critical patent/HUT65748A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU9303025A 1991-04-26 1992-03-16 Process for producing 4-aryl-3(heteroarylureido)-quinoline derivatives and pharmaceutical preparations containing them HUT65748A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69232391A 1991-04-26 1991-04-26

Publications (2)

Publication Number Publication Date
HU9303025D0 true HU9303025D0 (en) 1994-01-28
HUT65748A HUT65748A (en) 1994-07-28

Family

ID=24780107

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9303025A HUT65748A (en) 1991-04-26 1992-03-16 Process for producing 4-aryl-3(heteroarylureido)-quinoline derivatives and pharmaceutical preparations containing them

Country Status (20)

Country Link
EP (1) EP0590094A1 (en)
JP (1) JPH0776215B2 (en)
CN (1) CN1066068A (en)
AU (1) AU1879792A (en)
BR (1) BR9205939A (en)
CA (1) CA2108014A1 (en)
CZ (1) CZ395592A3 (en)
DE (1) DE9290049U1 (en)
FI (1) FI934710A0 (en)
HU (1) HUT65748A (en)
IE (1) IE921330A1 (en)
IL (1) IL101627A0 (en)
MX (1) MX9201916A (en)
NO (1) NO933837L (en)
NZ (1) NZ242493A (en)
PT (1) PT100426A (en)
TW (1) TW197436B (en)
WO (1) WO1992019614A1 (en)
YU (1) YU44592A (en)
ZA (1) ZA922976B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3323393A (en) * 1992-01-23 1993-09-01 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
DE69633059T2 (en) * 1995-05-31 2005-08-18 Sumitomo Pharmaceuticals Co., Ltd. NEW NAPHTHYRIDINE DERIVATIVES.
WO1998023615A1 (en) * 1996-11-26 1998-06-04 Sumitomo Pharmaceuticals Company, Limited Novel naphthyridine derivatives
CA2321237A1 (en) 1998-02-25 1999-09-02 Masami Muraoka Pyridone derivatives and process for producing the same
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
EP2284157A1 (en) * 2003-12-12 2011-02-16 Wyeth Quinolines useful in treating cardiovascular disease
CN103601677B (en) * 2013-11-19 2015-11-18 清华大学 Prepare the method for 2-alkylthio quinoline

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
TW205037B (en) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
CA2108014A1 (en) 1992-10-27
TW197436B (en) 1993-01-01
HUT65748A (en) 1994-07-28
NZ242493A (en) 1994-08-26
JPH0776215B2 (en) 1995-08-16
FI934710A (en) 1993-10-25
WO1992019614A1 (en) 1992-11-12
CN1066068A (en) 1992-11-11
IL101627A0 (en) 1992-12-30
YU44592A (en) 1994-12-28
CZ395592A3 (en) 1994-02-16
BR9205939A (en) 1994-09-27
MX9201916A (en) 1992-11-01
EP0590094A1 (en) 1994-04-06
IE921330A1 (en) 1992-11-04
NO933837L (en) 1993-10-25
ZA922976B (en) 1993-10-25
PT100426A (en) 1993-08-31
FI934710A0 (en) 1993-10-25
AU1879792A (en) 1992-12-21
JPH06501025A (en) 1994-01-27
DE9290049U1 (en) 1994-01-05

Similar Documents

Publication Publication Date Title
IL105806A0 (en) Aminoquinoline derivatives and pharmaceutical compositions containing the same
IL102764A0 (en) Quinazoline derivatives,and pharmaceutical compositions containing them
AU638346B2 (en) Carbostyril derivatives and pharmaceutical composition containing the same
GR3023258T3 (en) 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
IL103910A0 (en) New peptide derivatives and pharmaceutical compositions containing them
GB9108547D0 (en) Quinoline derivatives
IL105003A0 (en) Indole derivatives and pharmaceutical compositions containing them
IL101865A0 (en) Thiopyranopyrrole derivatives and their preparation
IL99902A0 (en) Indane and quinoline derivatives and pharmaceutical compositions containing the same
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
NZ227036A (en) Quinoline derivatives and pharmaceutical compositions containing such
NZ228098A (en) Quinoline derivatives and pharmaceutical compositions
ZA921279B (en) Substituted alpha-aminoaldehydes and derivatives
NZ227743A (en) Isoquinolinone derivatives and their pharmaceutical compositions
IL110033A0 (en) Bis-imide derivatives and pharmaceutical compositions containing them
IL104623A0 (en) Biphenyl-substituted quinoline derivatives and pharmaceutical compositions containing the same
IL100850A0 (en) Indole derivatives and pharmaceutical compositions containing them
IL102178A0 (en) Chroman derivatives and pharmaceutical compositions containing them
HU9303025D0 (en) 4-aryl-3(jheteroaryl-ureido)-quinoline derivatives and pharmaceutical preparatives containing them
IL103747A0 (en) Saccharin derivatives and pharmaceutical compositions containing them
IL113975A0 (en) 3-heteroaliphatyl- and 3-hetero (aryl) aliphatyl-2(1H)- quinolone derivatives and pharmaceutical co mpositions containing same
IL98680A0 (en) Hydroxamate derivatives and pharmaceutical compositions containing them
ZA912630B (en) New ethylene-substituted phenylalkylethylenediamine-platinum(ii or iv)derivatives and phenylalkylethylenediamines

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee
DNF4 Restoration of lapsed final protection
DFC4 Cancellation of temporary protection due to refusal